Literature DB >> 20639084

Innate immunity and steatohepatitis: a critical role of another toll (TLR-9).

Bin Gao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20639084      PMCID： PMC2923427          DOI： 10.1053/j.gastro.2010.05.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  31 in total

1.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Authors:  Kouichi Miura; Yuzo Kodama; Sayaka Inokuchi; Bernd Schnabl; Tomonori Aoyama; Hirohide Ohnishi; Jerrold M Olefsky; David A Brenner; Ekihiro Seki
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

2.  Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages.

Authors:  Dominic De Nardo; Christine M De Nardo; Thao Nguyen; John A Hamilton; Glen M Scholz
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

3.  Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

Authors:  Gyongyi Szabo; Arumugam Velayudham; Laszlo Romics; Pranoti Mandrekar
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

4.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A J Wigg; I C Roberts-Thomson; R B Dymock; P J McCarthy; R H Grose; A G Cummins
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis.

Authors:  Kentaro Kikuchi; Zhe-Xiong Lian; Guo-Xiang Yang; Aftab A Ansari; Susumu Ikehara; Marshall Kaplan; Hiroshi Miyakawa; Ross L Coppel; M Eric Gershwin
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

6.  Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance.

Authors:  Alexander H Dalpke; Martin D Lehner; Thomas Hartung; Klaus Heeg
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

Review 7.  Oxidants and antioxidants in alcohol-induced liver disease.

Authors:  Gavin E Arteel
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

8.  Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.

Authors:  Rinke Stienstra; Fredy Saudale; Caroline Duval; Shohreh Keshtkar; Johanna E M Groener; Nico van Rooijen; Bart Staels; Sander Kersten; Michael Müller
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

9.  Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion.

Authors:  Zubin M Bamboat; Lee M Ocuin; Vinod P Balachandran; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  J Clin Invest       Date:  2010-01-19       Impact factor: 14.808

10.  Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

Authors:  Golo Ahlenstiel; Rachel H Titerence; Christopher Koh; Birgit Edlich; Jordan J Feld; Yaron Rotman; Marc G Ghany; Jay H Hoofnagle; T Jake Liang; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2009-09-10       Impact factor: 22.682
View more
  8 in total

Review 1.  Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

Authors:  Ekihiro Seki; Bernd Schnabl
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

Review 2.  Innate immunity in alcoholic liver disease.

Authors:  Bin Gao; Ekihiro Seki; David A Brenner; Scott Friedman; Jessica I Cohen; Laura Nagy; Gyongyi Szabo; Samir Zakhari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-20       Impact factor: 4.052

3.  Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?

Authors:  Priya Handa; Akhila Vemulakonda; Kris V Kowdley; Misael Uribe; Nahum Méndez-Sánchez
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

4.  NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.

Authors:  Auvro R Mridha; Alexander Wree; Avril A B Robertson; Matthew M Yeh; Casey D Johnson; Derrick M Van Rooyen; Fahrettin Haczeyni; Narci C-H Teoh; Christopher Savard; George N Ioannou; Seth L Masters; Kate Schroder; Matthew A Cooper; Ariel E Feldstein; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2017-02-03       Impact factor: 25.083

5.  Treprostinil alleviates hepatic mitochondrial injury during rat renal ischemia-reperfusion injury.

Authors:  Joyce Hou; Evelyn Tolbert; Mark Birkenbach; Nisanne S Ghonem
Journal:  Biomed Pharmacother       Date:  2021-09-21       Impact factor: 6.529

Review 6.  Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.

Authors:  Saumya Jayakumar; Rohit Loomba
Journal:  Aliment Pharmacol Ther       Date:  2019-05-31       Impact factor: 8.171

Review 7.  Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis.

Authors:  Luisa Vonghia; Peter Michielsen; Sven Francque
Journal:  Int J Mol Sci       Date:  2013-10-01       Impact factor: 5.923

8.  Natural killer cell-dependent anti-fibrotic pathway in liver injury via Toll-like receptor-9.

Authors:  Lina Abu-Tair; Jonathan H Axelrod; Sarit Doron; Yossi Ovadya; Valery Krizhanovsky; Eithan Galun; Johnny Amer; Rifaat Safadi
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.